Clinical trial Recruiting at 1 site Interventional Ages 2 to 7

Dexmedetomidine added to bupivacaine caudal block for children having open appendectomy.

Official title: The Effectiveness of Dexmedetomidine as an Adjuvant for Bupivacaine Caudal Block in Pediatric Open Appendectomy Under General Anesthesia

Run by Ain Shams University · NCT07088900 · Data updated 2026-11-12

This trial will test whether adding dexmedetomidine to bupivacaine in a caudal block gives children longer and better pain relief and fewer emergence problems after open appendectomy.

More Pediatric Cancer trials

Quick facts

Study typeInterventional
Ages2 Years to 7 Years
SexAll
Enrollment60 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedJune 30, 2026
Study endsJuly 30, 2026
Registry record updatedMay 6, 2026
Trial IDNCT07088900 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children scheduled for open appendectomy under general anesthesia who are ASA physical status I–II and whose legal guardians can provide written informed consent are appropriate candidates.

Probably not a fit

Children with known allergy to local anesthetics or dexmedetomidine, coagulation disorders, active infection at the injection site, significant lumbosacral spine abnormalities, pre-existing neurological or psychiatric disorders, severe asthma, or anticipated surgery longer than 2.5 hours would not be expected to benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children (ASA I–II) undergoing open appendectomy under general anesthesia at Ain Shams University will receive a caudal block with either bupivacaine alone or bupivacaine plus dexmedetomidine. Investigators will record pain scores, duration of postoperative analgesia, time to first analgesic request, opioid consumption, incidence of emergence delirium, and any adverse events. Recovery quality measures and safety monitoring will be compared between the two groups. Standard anesthetic care will be maintained for all participants.

Why it matters

Potential benefit: If successful, the combination could provide longer-lasting pain relief after surgery, reduce opioid use, and lead to smoother recoveries for children.

How similar studies have gone: Similar pediatric trials of dexmedetomidine added to caudal bupivacaine have often shown improved postoperative analgesia and reduced emergence agitation, though dosing and safety data vary.

Who can join: the full rules

Show full inclusion / exclusion criteria
inclusion criteria:

* ASA (American Society of Anesthesiologists) physical status I or II.
* Legal guardian provides written informed consent. Exclusion Criteria
* Refusal of participation by the legal guardian.
* Known allergy or hypersensitivity to local anesthetics or dexmedetomidine.
* Coagulation disorder or receiving anticoagulant therapy.
* Active infection at or near the injection site.
* Significant anatomical abnormalities of the lumbosacral spine.
* Pre-existing neurological disorders, psychiatric disorders, or a history of convulsions.
* Anticipated surgery time of more than 2.5 hours.
* Patients with severe asthma or active wheezing.

Where it's running

  • Ain Shams university hospitals
    Cairo, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.